PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Yusen Logistics extends business with AstraZeneca

AstraZeneca has awarded an important contract extension to award-winning healthcare logistics provider Yusen Logistics for the global distribution of its products.
As a Strategic Global Freight Partner to AstraZeneca, Yusen handles product throughout the manufacturing process, from active ingredient and bulk materials to prescription drugs.
The contract extension covers existing road business, air and sea volumes handled by Yusen Logistics.
The Yusen solution is based around its European Pharma Superhighway road network, with movements managed by its ‘Control Tower’. This allows centralised planning of pan-European transport movements to maximise vehicle utilisation and reduce costs, whilst ensuring product integrity at all times. The Control Tower also manages air movements via strategic gateways at Schiphol, Frankfurt and Chicago, as well as ocean movements to and from Europe, supported by Yusen’s GDP licenced warehouses in Antwerp and the UK, which deliver strategic storage and Customs Clearance capabilities.
The Pharma Superhighway currently carries circa 250,000 pallets for AstraZeneca, all of which are real time tracked with full temperature monitoring, from its manufacturing plants and third party manufacturers to over 100 destinations in Europe and 50 countries worldwide.
The two companies have been working in close partnership since 2007, when Yusen Logistics was appointed to work with AstraZeneca on the creation of a lean supply chain. Since that time, Yusen has consistently demonstrated year on year cost savings and service enhancements.
Andy Fitt, Deputy MD Yusen Logistics (UK) commented: “This renewal underlines the continued evolution of our collaboration with AstraZeneca. As a long-standing partner we are continuing to proactively deliver service and quality enhancements on a local, regional and global basis.”
Julian Wann, Global Category Lead: Freight & Logistics, at AZ, commented: “We are delighted to continue and further develop our strategic partnership with Yusen Logistics, working together to support AZ’s business objectives.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026